Could isotretinoin be a protective agent against COVID-19?: A dermatologist perspective
J Cosmet Dermatol
.
2021 Aug;20(8):2394-2395.
doi: 10.1111/jocd.14239.
Epub 2021 Jun 6.
Authors
Ayman Abdelmaksoud
1
,
Anant Patil
2
,
Recep Dursun
3
,
Selami Aykut Temiz
4
,
Erhan Ayhan
5
,
Mohamad Goldust
6
,
Michelangelo Vestita
7
8
Affiliations
1
Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
2
Department of Pharmacology, Dr. DY Patil Medical College, Navi Mumbai, India.
3
Department of Dermatology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
4
Department of Dermatology, Konya Ereğli State Hospital, Konya, Turkey.
5
University of Health Science Gazi Yaşargil Training and Research Hospital, Diyarbakir, Turkey.
6
Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
7
Unit of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
8
Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
PMID:
34008285
PMCID:
PMC8242528
DOI:
10.1111/jocd.14239
No abstract available
Keywords:
COVID-19; isotretinoin; skin.
Publication types
Letter
MeSH terms
Acne Vulgaris* / drug therapy
COVID-19*
Dermatologists
Humans
Isotretinoin
Protective Agents
SARS-CoV-2
Substances
Protective Agents
Isotretinoin